Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)

Market Cap	26.13B +7.6%
Revenue (ttm)	5.90B -17.4%
Net Income	1.74B -18.3%
EPS	1.89 -18.5%
Shares Out	921.66M
PE Ratio	15.00
Forward PE	n/a
Dividend	2.09 (7.22%)
Ex-Dividend Date	Jun 30, 2025

Volume	2,926,600
Average Volume	7,046,197
Open	28.27
Previous Close	28.35
Day's Range	28.12 - 28.86
52-Week Range	24.12 - 29.60
Beta	0.17
RSI	59.82
Earnings Date	Apr 24, 2026

About SHA:600566

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. The company offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatrics; oral and skin care products; and anti-fatigue, anti-aging, antioxidant, and immunity-enhancing Chinese medicine health products. It also develops Chinese a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Fei Cao
• Employees: 5,026
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600566

Financial Performance

In 2025, SHA:600566's revenue was 6.22 billion, a decrease of -22.43% compared to the previous year's 8.02 billion. Earnings were 1.78 billion, a decrease of -29.77%.